000			01343 a2200409 4500
005			20250514004025.0
264		0	_c20010906
008			200109s 0 0 eng d
022			_a0036-8075
024	7		_a10.1126/science.1061861 _2doi
040			_aNLM _beng _cNLM
100	1		_aGupta, R
245	0	0	_aPublic health. Responding to market failures in tuberculosis control. _h[electronic resource]
260			_bScience (New York, N.Y.) _cAug 2001
300			_a1049-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntitubercular Agents _xeconomics
650	0	4	_aDrug Costs
650	0	4	_aDrug Industry
650	0	4	_aDrugs, Essential
650	0	4	_aHealth Policy
650	0	4	_aHumans
650	0	4	_aPatents as Topic
650	0	4	_aPilot Projects
650	0	4	_aPolicy Making
650	0	4	_aTuberculosis _xdrug therapy
650	0	4	_aTuberculosis, Multidrug-Resistant _xdrug therapy
650	0	4	_aWorld Health Organization
700	1		_aKim, J Y
700	1		_aEspinal, M A
700	1		_aCaudron, J M
700	1		_aPecoul, B
700	1		_aFarmer, P E
700	1		_aRaviglione, M C
773	0		_tScience (New York, N.Y.) _gvol. 293 _gno. 5532 _gp. 1049-51
856	4	0	_uhttps://doi.org/10.1126/science.1061861 _zAvailable from publisher's website
999			_c11391753 _d11391753